Satoru Suzuki Selected Research

Reactive Oxygen Species (Oxygen Radicals)

1/2021	Clinical significance of reactive oxidative metabolites in patients with heart failure with reduced left ventricular ejection fraction.
1/2021	Impact of Reactive Oxidative Metabolites Among New Categories of Nonischemic Heart Failure.
1/2009	Atypical early onset of diabetes, deafness and lung cancer in a male patient with mitochondrial mutations in peripheral mononuclear cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Satoru Suzuki Research Topics

Disease

16	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 10/2002
14	Neoplasms (Cancer) 01/2020 - 08/2003
9	Heart Failure 01/2021 - 03/2004
6	Thrombosis (Thrombus) 01/2021 - 01/2010
6	Spasm (Spasms) 01/2021 - 03/2004
6	Carcinoma (Carcinomatosis) 01/2013 - 10/2002
5	Atrial Fibrillation 02/2022 - 01/2020
4	Hemorrhage 01/2022 - 03/2020
3	Overweight 03/2024 - 01/2018
3	Thyroid Nodule (Nodule, Thyroid) 03/2024 - 01/2016
3	Inflammation (Inflammations) 02/2021 - 01/2020
3	Myocardial Infarction 11/2020 - 09/2004
3	Hypertrophy 03/2020 - 03/2006
3	Obesity 01/2020 - 01/2019
3	Diabetes Mellitus 09/2019 - 06/2002
3	Thyrotoxicosis 01/2013 - 12/2011
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 02/2024 - 02/2022
2	Cardiomegaly (Heart Hypertrophy) 02/2024 - 03/2006
2	Hypertension (High Blood Pressure) 02/2024 - 02/2022
2	ST Elevation Myocardial Infarction 02/2022 - 05/2011
2	Malnutrition (Nutritional Deficiencies) 01/2022 - 04/2007
2	Hyperemia 01/2021 - 01/2020
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2021
2	Left Ventricular Dysfunction 01/2021 - 01/2021
2	Cardiomyopathies (Cardiomyopathy) 10/2020 - 10/2008
2	Infarction (Infarctions) 03/2020 - 01/2016
2	Disease Progression 01/2020 - 01/2009
2	Pulmonary Hypertension 01/2020 - 01/2014
2	Adenoma (Adenomas) 01/2014 - 01/2009
2	Autoimmune Hypophysitis 01/2014 - 01/2010
2	Lymphoma (Lymphomas) 01/2009 - 05/2003
2	Hepatitis 01/2008 - 01/2007
2	Hepatocellular Carcinoma (Hepatoma) 12/2006 - 12/2003
2	Infections 12/2006 - 10/2002
2	Vascular Diseases (Vascular Disease) 11/2003 - 05/2000
1	Papillary Thyroid Cancer 11/2022
1	Ischemia 02/2022
1	Reperfusion Injury 02/2022
1	Epilepsy (Aura) 11/2021
1	Aortic Valve Insufficiency (Aortic Regurgitation) 01/2021
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2021
1	Collagen Diseases (Collagen Disease) 01/2021
1	Death (Near-Death Experience) 12/2020
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 10/2020
1	Carpal Tunnel Syndrome 10/2020
1	Hypothyroidism 01/2020
1	Tachycardia (Tachyarrhythmias) 01/2020
1	Congenital Hypothyroidism (Cretinism) 01/2020

Drug/Important Bio-Agent (IBA)

6	Thyroid HormonesIBA 11/2022 - 12/2011
5	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2021 - 03/2004
4	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2020 - 09/2004
3	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 02/2024 - 08/2007
3	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 11/2022 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 02/2021 - 01/2019
3	C-Reactive ProteinIBA 01/2021 - 12/2006
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2009
3	SodiumIBA 10/2020 - 03/2006
3	SteroidsIBA 01/2014 - 01/2009
3	Proteins (Proteins, Gene)FDA Link 01/2013 - 01/2008
3	Messenger RNA (mRNA)IBA 12/2006 - 12/2003
2	Antihypertensive Agents (Antihypertensives)IBA 02/2024 - 01/2020
2	esaxerenoneIBA 02/2024 - 02/2022
2	ORALIT (ORS)IBA 11/2022 - 08/2016
2	Aldehyde DehydrogenaseIBA 02/2022 - 02/2022
2	Oxygen (Dioxygen)IBA 01/2021 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2020 - 09/2018
2	RivaroxabanIBA 11/2020 - 03/2020
2	Amyloid (Amyloid Fibrils)IBA 10/2020 - 03/2004
2	Insulin (Novolin)FDA Link 01/2020 - 06/2002
2	Thyroglobulin FDA Link 01/2018 - 10/2002
2	mu-CrystallinsIBA 07/2010 - 09/2007
2	2,4-thiazolidinedione (thiazolidinedione)IBA 01/2008 - 01/2007
2	EnzymesIBA 01/2008 - 06/2002
2	Pioglitazone (Actos)FDA Link 01/2008 - 01/2007
2	LigandsIBA 01/2008 - 12/2003
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 11/2007 - 08/2007
2	NitratesIBA 08/2007 - 05/2006
2	Thymidine KinaseIBA 08/2003 - 10/2002
2	Ganciclovir (Cytovene)FDA LinkGeneric 08/2003 - 10/2002
1	AldehydesIBA 02/2022
1	Mitochondrial Aldehyde DehydrogenaseIBA 02/2022
1	Prealbumin (Transthyretin)IBA 10/2020
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 07/2020
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 03/2020
1	Factor Xa (Coagulation Factor Xa)IBA 03/2020
1	Proteinase-Activated ReceptorsIBA 03/2020
1	flowable hybrid composite (Flow-It)IBA 01/2020
1	NucleotidesIBA 01/2020
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2020
1	Adenosine (Adenocard)FDA LinkGeneric 01/2020

Therapy/Procedure

12	Nuclear Power Plants 03/2024 - 01/2016
11	Therapeutics 01/2021 - 06/2002
4	Percutaneous Coronary Intervention 02/2022 - 01/2021
3	Prostheses and Implants (Prosthesis) 01/2016 - 01/2010
2	Catheter Ablation 01/2021 - 01/2020
2	Renal Dialysis (Hemodialysis) 01/2021 - 11/2003
2	Operative Surgical Procedures 01/2010 - 10/2004
1	Implanted Electrodes 11/2021
1	Glycemic Control 02/2021
1	Critical Care (Surgical Intensive Care) 01/2021